Kitakatsuragi, Japan

Toshihiro Fujioka

This inventor holds 3 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihiro Fujioka. Retrieved from https://idiyas.com/inventor/toshihiro-fujioka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Kitakatsuragi, JP (1993)
  • Nara, JP (1993)

Company Filing History:


Years Active: 1993

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Toshihiro Fujioka

Introduction

Toshihiro Fujioka is a notable inventor based in Kitakatsuragi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of dipeptide derivatives. With a total of 3 patents to his name, Fujioka's work has the potential to impact the treatment of hypertension.

Latest Patents

Fujioka's latest patents focus on dipeptide derivatives that are capable of inhibiting the enzymatic activity of renin. This inhibition plays a crucial role in depressing the renin-angiotensin system, which in turn helps in lowering blood pressure. The dipeptide derivatives are characterized by a specific formula, where R¹ can be a variety of alkyl, alkenyl, alkynyl, cycloalkyl, aryl, or heterocyclic radicals.

Career Highlights

Fujioka is currently associated with Shionogi Company Limited, a prominent pharmaceutical company. His work at Shionogi has allowed him to explore innovative solutions in drug development, particularly in cardiovascular health.

Collaborations

Throughout his career, Fujioka has collaborated with esteemed colleagues such as Kunio Hayashi and Tatsuo Toyoda. These collaborations have further enriched his research and development efforts.

Conclusion

Toshihiro Fujioka's contributions to the field of pharmaceuticals through his innovative dipeptide derivatives highlight his role as a significant inventor. His work continues to pave the way for advancements in hypertension treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…